D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 137 Citations 73,300 685 World Ranking 766 National Ranking 467

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Diabetes mellitus
  • Disease

His scientific interests lie mostly in Internal medicine, Kidney disease, Renal function, Creatinine and Endocrinology. His Internal medicine research includes elements of Surgery and Cardiology. His studies in Kidney disease integrate themes in fields like Diabetes mellitus, Nephrology, End stage renal disease and Intensive care medicine.

Michael G. Shlipak studies Renal function, namely Cystatin C. He has included themes like Genome-wide association study, Cohort, Pathology, Urinary system and Biomarker in his Creatinine study. The Endocrinology study combines topics in areas such as Gastroenterology, Lipodystrophy and Meta-analysis.

His most cited work include:

  • Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. (2470 citations)
  • Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease (1950 citations)
  • Cystatin C and the risk of death and cardiovascular events among elderly persons. (1033 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Internal medicine, Renal function, Kidney disease, Endocrinology and Creatinine. The concepts of his Internal medicine study are interwoven with issues in Diabetes mellitus and Cardiology. He is involved in the study of Renal function that focuses on Cystatin C in particular.

As a member of one scientific family, Michael G. Shlipak mostly works in the field of Kidney disease, focusing on Cohort study and, on occasion, Intensive care medicine. His Endocrinology research is multidisciplinary, incorporating elements of Fibroblast growth factor 23, Case-control study and C-reactive protein. Michael G. Shlipak combines subjects such as Acute kidney injury, Urine, Urinary system and Pathology with his study of Creatinine.

He most often published in these fields:

  • Internal medicine (110.92%)
  • Renal function (78.41%)
  • Kidney disease (68.92%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (110.92%)
  • Kidney disease (68.92%)
  • Renal function (78.41%)

In recent papers he was focusing on the following fields of study:

Michael G. Shlipak mostly deals with Internal medicine, Kidney disease, Renal function, Albuminuria and Creatinine. Internal medicine and Cardiology are frequently intertwined in his study. His study looks at the intersection of Kidney disease and topics like Urine with Albumin.

His research in Renal function is mostly focused on Cystatin C. His Albuminuria research includes themes of Nephrology and Intensive care medicine. His Creatinine research incorporates themes from Gastroenterology and End stage renal disease.

Between 2017 and 2021, his most popular works were:

  • Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINT. (53 citations)
  • Kidney Damage Biomarkers and Incident Chronic Kidney Disease During Blood Pressure Reduction: A Case-Control Study. (33 citations)
  • Effect of Intensive Blood Pressure Lowering on Kidney Tubule Injury: Findings From the ACCORD Trial Study Participants (19 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Diabetes mellitus
  • Disease

Michael G. Shlipak mainly investigates Renal function, Kidney disease, Internal medicine, Albuminuria and Biomarker. He has researched Renal function in several fields, including Urology, Urine, Tamm–Horsfall protein, Proportional hazards model and Hazard ratio. His studies deal with areas such as Diabetes mellitus, Blood pressure, Urinary system, Creatinine and Prospective cohort study as well as Kidney disease.

Cystatin C is the focus of his Creatinine research. The various areas that Michael G. Shlipak examines in his Internal medicine study include Gastroenterology and Cardiology. His research in Albuminuria intersects with topics in Psychological intervention, Socioeconomic status, Intervention and Intensive care medicine.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.

Kunihiro Matsushita;Marije van der Velde;Brad C. Astor;Mark Woodward.
The Lancet (2010)

3931 Citations

Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease

A Levin;PE Stevens;RW Bilous;J Coresh.
Kidney International (2013)

1950 Citations

Cystatin C and the risk of death and cardiovascular events among elderly persons.

Michael G. Shlipak;Mark J. Sarnak;Ronit Katz;Linda F. Fried.
The New England Journal of Medicine (2005)

1419 Citations

Renal Impairment and Outcomes in Heart Failure: Systematic Review and Meta-Analysis

Grace L. Smith;Judith H. Lichtman;Michael B. Bracken;Michael G. Shlipak;Michael G. Shlipak.
Journal of the American College of Cardiology (2006)

1031 Citations

Long-term Risk of Mortality and Other Adverse Outcomes After Acute Kidney Injury: A Systematic Review and Meta-analysis

Steven G. Coca;Bushra Yusuf;Bushra Yusuf;Michael G. Shlipak;Michael G. Shlipak;Amit X. Garg.
American Journal of Kidney Diseases (2009)

999 Citations

Elevations of Inflammatory and Procoagulant Biomarkers in Elderly Persons With Renal Insufficiency

Michael G. Shlipak;Linda F. Fried;Casey Crump;Anthony J. Bleyer.
Circulation (2003)

935 Citations

Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain.

John G. Canto;Michael G. Shlipak;William J. Rogers;Judith A. Malmgren.
JAMA (2000)

925 Citations

Cardiovascular Mortality Risk in Chronic Kidney Disease: Comparison of Traditional and Novel Risk Factors

Michael G. Shlipak;Linda F. Fried;Mary Cushman;Teri A. Manolio.
JAMA (2005)

818 Citations

Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection

Jacqueline Neuhaus;David R. Jacobs;Jason V. Baker;Jason V. Baker;Alexandra Calmy.
The Journal of Infectious Diseases (2010)

803 Citations

New loci associated with kidney function and chronic kidney disease

Anna Köttgen;Anna Köttgen;Cristian Pattaro;Carsten A. Böger;Christian Fuchsberger.
Nature Genetics (2010)

746 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Michael G. Shlipak

Josef Coresh

Josef Coresh

Johns Hopkins University

Publications: 284

Andrew S. Levey

Andrew S. Levey

Tufts Medical Center

Publications: 165

Chirag R. Parikh

Chirag R. Parikh

Johns Hopkins University

Publications: 157

Joachim H. Ix

Joachim H. Ix

University of California, San Diego

Publications: 153

Caroline S. Fox

Caroline S. Fox

National Institutes of Health

Publications: 145

Alan S. Go

Alan S. Go

Kaiser Permanente

Publications: 134

Chi-yuan Hsu

Chi-yuan Hsu

University of California, San Francisco

Publications: 131

Anna Köttgen

Anna Köttgen

University of Freiburg

Publications: 131

Marcello Tonelli

Marcello Tonelli

University of Calgary

Publications: 126

Csaba P. Kovesdy

Csaba P. Kovesdy

University of Tennessee Health Science Center

Publications: 119

Kamyar Kalantar-Zadeh

Kamyar Kalantar-Zadeh

University of California, Irvine

Publications: 117

Brenda R. Hemmelgarn

Brenda R. Hemmelgarn

University of Alberta

Publications: 110

Johan Ärnlöv

Johan Ärnlöv

Karolinska Institute

Publications: 109

Ian H. de Boer

Ian H. de Boer

University of Washington

Publications: 108

Ron T. Gansevoort

Ron T. Gansevoort

University Medical Center Groningen

Publications: 103

Harold I. Feldman

Harold I. Feldman

University of Pennsylvania

Publications: 100

Trending Scientists

Simon A. Austin

Simon A. Austin

Loughborough University

Fujio Izumi

Fujio Izumi

Kyoto University

Xinyu Xue

Xinyu Xue

University of Electronic Science and Technology of China

Salvador Nogués

Salvador Nogués

University of Barcelona

Noel T. Keen

Noel T. Keen

University of California, Riverside

Joan Cerdà

Joan Cerdà

Autonomous University of Barcelona

Bryan T. Eaton

Bryan T. Eaton

Australian Centre for Disease Preparedness

Christopher J. Talbot

Christopher J. Talbot

Uppsala University

Derek Keir

Derek Keir

University of Florence

Stefan Dech

Stefan Dech

German Aerospace Center

Marc Voltz

Marc Voltz

INRAE : Institut national de recherche pour l'agriculture, l'alimentation et l'environnement

Henk van Loveren

Henk van Loveren

Maastricht University

Cora N. Sternberg

Cora N. Sternberg

Cornell University

Ronald M. Bukowski

Ronald M. Bukowski

Cleveland Clinic

Shamir R. Mehta

Shamir R. Mehta

Population Health Research Institute

Something went wrong. Please try again later.